SEC-sourced researchBeta
RGBP
Regen BioPharma Inc
Company comparison ↗
Data passport
- CIK
- 0001589150
- Exchange
- OTC
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Dec 30, 2025
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| September 2024 | 236,560.0000 | Dec 30, 2025 |
| September 2025 | 236,561.0000 | Dec 30, 2025 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| September 2025 | 236,561.0000 | -1,274,502.0000 | -383,591.0000 | 274,628.0000 | 6,555,811.0000 | Dec 30, 2025 |
| September 2024 | 236,560.0000 | -668,255.0000 | -751,536.0000 | 161,084.0000 | 5,378,456.0000 | Dec 30, 2025 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $236.56K | September 2025 | Dec 30, 2025 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $236.56K | September 2024 | Dec 30, 2025 | 10-K |
| Net incomeNetIncomeLoss | -$1.27M | September 2025 | Dec 30, 2025 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$383.59K | September 2025 | Dec 30, 2025 | 10-K |
| Total assetsAssets | $274.63K | September 2025 | Dec 30, 2025 | 10-K |
| Total liabilitiesLiabilities | $6.56M | September 2025 | Dec 30, 2025 | 10-K |